GO:0008460 dTDP-glucose 4,6-dehydratase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008460 describes the molecular function dTDP-glucose 4,6-dehydratase activity, which catalyzes the conversion of dTDP-glucose to dTDP-4-dehydro-6-deoxy-alpha-D-glucose and water.
• The reaction proceeds through a NAD+-dependent oxidation, dehydration, and NADH re-reduction mechanism, with key active-site residues including Thr134, Tyr160, Lys164, Glu136, and Asp135.
• dTDP-glucose 4,6-dehydratase (RmlB) is essential for the biosynthesis of dTDP-rhamnose, a precursor of cell wall polysaccharides in bacteria and fungi.
• In Candida albicans, UDP-glucose 4,6-dehydratase activity is critical for cell wall integrity and virulence.
• The enzyme is a validated target for antibacterial and antifungal drug discovery, with high-throughput screening assays developed for Mycobacterium tuberculosis.
• CRISPR-based knockout, point mutation, and knock-in models enable precise functional dissection of dTDP-glucose 4,6-dehydratase in diverse organisms.
Description
dTDP-glucose 4,6-dehydratase activity (GO:0008460) is a molecular function that catalyzes the dehydration of dTDP-glucose to dTDP-4-dehydro-6-deoxy-alpha-D-glucose, the first committed step in the biosynthesis of dTDP-rhamnose. This reaction is essential for the production of rhamnose-containing cell wall polysaccharides in bacteria and fungi, making it a critical component of cell envelope biogenesis and a target for antimicrobial development. The enzyme is widely conserved across prokaryotes and eukaryotes, and its mechanism has been extensively studied using rapid mix-quench mass spectrometry and site-directed mutagenesis. Researchers study GO:0008460 to understand carbohydrate metabolism, cell wall assembly, and to develop inhibitors against pathogenic microorganisms such as Mycobacterium tuberculosis and Candida albicans. The availability of enzymatic assays and structural data has facilitated high-throughput screening and mechanistic investigations.
dTDP-glucose 4,6-dehydratase activity At A Glance
| GO ID | GO:0008460 |
|---|---|
| GO term | dTDP-glucose 4,6-dehydratase activity |
| Ontology | molecular_function |
| Synonym | dTDPglucose 4,6-dehydratase activity; dTDP-glucose 4,6-hydro-lyase activity; TDP-glucose oxidoreductase activity; thymidine diphosphoglucose oxidoreductase activity |
| Major function | Catalyzes the dehydration of dTDP-glucose to dTDP-4-dehydro-6-deoxy-alpha-D-glucose and water |
| Reaction | dTDP-glucose = dTDP-4-dehydro-6-deoxy-alpha-D-glucose + H2O |
| Cofactor | NAD+ (tightly bound) |
| Pathway | dTDP-rhamnose biosynthesis |
| EC number | 4.2.1.46 |
What Is GO:0008460?
dTDP-glucose 4,6-dehydratase activity (GO:0008460) is defined as the catalysis of the reaction: dTDP-glucose = dTDP-4-dehydro-6-deoxy-alpha-D-glucose + H2O. This enzymatic activity removes a water molecule from dTDP-glucose, generating a 4-keto-6-deoxy sugar nucleotide intermediate that serves as a precursor for various deoxysugars, including dTDP-rhamnose.
Why Is dTDP-glucose 4,6-dehydratase activity Important in Cell Biology?
dTDP-glucose 4,6-dehydratase activity is essential for the biosynthesis of dTDP-rhamnose, a key component of cell wall polysaccharides in many pathogenic bacteria and fungi. Inhibition of this enzyme disrupts cell wall integrity and attenuates virulence, making it a promising target for antimicrobial drug discovery. Additionally, the enzyme is a model system for studying dehydration mechanisms in carbohydrate metabolism, with detailed kinetic and structural studies revealing concerted and stepwise catalytic pathways.
• Provides the first committed step in dTDP-rhamnose biosynthesis, a precursor for cell wall polysaccharides.
• Essential for cell wall integrity and virulence in Candida albicans.
• Validated drug target for Mycobacterium tuberculosis, with high-throughput screening assays available.
• Mechanistic studies have identified critical active-site residues (Thr134, Tyr160, Lys164, Glu136, Asp135).
• Enables one-pot enzymatic production of dTDP-4-keto-6-deoxy-D-glucose for synthetic applications.
• Serves as a paradigm for NAD+-dependent dehydration reactions in carbohydrate metabolism.
• Conserved across bacteria, fungi, and plants, facilitating comparative studies.
• Its inhibition can sensitize pathogens to existing antibiotics.
Molecular Mechanism of dTDP-glucose 4,6-dehydratase activity
Substrate Binding and Oxidation
In simple terms: The enzyme grabs dTDP-glucose and uses NAD+ to remove hydride from the sugar.
The reaction begins with the binding of dTDP-glucose to the active site, where NAD+ is tightly bound. The enzyme catalyzes the oxidation of the 4'-hydroxyl group of the glucose moiety, transferring a hydride to NAD+ to form NADH and a 4-keto intermediate. Rapid mix-quench mass spectrometry has confirmed the formation of this keto intermediate.
Dehydration Step
In simple terms: A water molecule is removed from the sugar, creating a double bond.
Following oxidation, the 4-keto intermediate undergoes dehydration, eliminating the 5'-hydroxyl group as water to form a 4,6-dideoxy sugar. Site-directed mutagenesis studies have identified Glu136 and Asp135 as critical catalytic residues for this dehydration step. The mechanism can proceed via concerted or stepwise pathways depending on the enzyme source.
NADH Re-reduction and Product Release
In simple terms: NADH returns its hydride to the sugar, completing the reaction and releasing the product.
The final step involves the transfer of hydride from NADH back to the 4-keto group, reducing it to a hydroxyl and regenerating NAD+. This step yields the product dTDP-4-dehydro-6-deoxy-alpha-D-glucose. Mutagenesis of Thr134, Tyr160, and Lys164 has revealed their roles in stabilizing the transition state and facilitating hydride transfer.
Active Site Architecture and Cofactor Regeneration
In simple terms: The enzyme's active site is built to hold NAD+ and the sugar in the right positions.
The active site of dTDP-glucose 4,6-dehydratase is a TIM-barrel fold with a deep pocket that accommodates both NAD+ and the substrate. Key residues such as Thr134, Tyr160, Lys164, Glu136, and Asp135 are positioned to stabilize the cofactor and catalyze the reaction steps. The enzyme does not release NAD+ during turnover; instead, it remains bound and is regenerated in situ.
Key Genes Involved in GO:0008460 dTDP-glucose 4,6-dehydratase activity
The following genes encode dTDP-glucose 4,6-dehydratase or related enzymes involved in dTDP-rhamnose biosynthesis and cell wall metabolism.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RmlB (E. coli) | dTDP-glucose 4,6-dehydratase | Model enzyme for mechanistic studies |
| RmlB (M. tuberculosis) | dTDP-glucose 4,6-dehydratase | Drug target; high-throughput screening |
| RmlB (C. albicans) | UDP-glucose 4,6-dehydratase | Cell wall integrity and virulence |
| RmlA | Glucose-1-phosphate thymidylyltransferase | Produces dTDP-glucose for dehydratase |
| RmlC | dTDP-4-keto-6-deoxyglucose 3,5-epimerase | Downstream of dehydratase in rhamnose pathway |
| RmlD | dTDP-4-keto-rhamnose reductase | Final step in dTDP-rhamnose synthesis |
| Gmd | GDP-mannose 4,6-dehydratase | Homologous enzyme in GDP-fucose pathway |
| Fcl | GDP-fucose synthetase | Downstream of Gmd |
| UXS1 | UDP-glucuronate decarboxylase | Related sugar nucleotide metabolism |
| TSTA3 | GDP-L-fucose synthase | Human homolog in fucose pathway |
| GMDS | GDP-mannose 4,6-dehydratase | Human homolog; involved in fucosylation |
| RmlB (S. aureus) | dTDP-glucose 4,6-dehydratase | Cell wall biosynthesis |
| RmlB (P. aeruginosa) | dTDP-glucose 4,6-dehydratase | Biofilm and virulence |
| RmlB (K. pneumoniae) | dTDP-glucose 4,6-dehydratase | Capsule polysaccharide synthesis |
| RmlB (S. pneumoniae) | dTDP-glucose 4,6-dehydratase | Teichoic acid biosynthesis |
| RmlB (B. subtilis) | dTDP-glucose 4,6-dehydratase | Spore coat polysaccharide |
| RmlB (M. smegmatis) | dTDP-glucose 4,6-dehydratase | Model for mycobacterial cell wall |
How Is dTDP-glucose 4,6-dehydratase activity Regulated?
The expression and activity of dTDP-glucose 4,6-dehydratase are regulated at multiple levels. In bacteria, the rml operon is often controlled by transcriptional regulators responsive to cell envelope stress. In Candida albicans, the enzyme is essential for cell wall integrity, and its expression is modulated during morphogenesis and biofilm formation. Additionally, the enzyme's activity can be feedback-inhibited by downstream metabolites such as dTDP-rhamnose. However, specific regulatory mechanisms remain to be fully elucidated.
dTDP-glucose 4,6-dehydratase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RmlB (M. tuberculosis) | Tuberculosis | Knockout in M. tuberculosis; macrophage infection |
| RmlB (C. albicans) | Candidiasis | Knockout in C. albicans; mouse systemic infection |
| RmlB (S. aureus) | Staphylococcal infections | Knockout in S. aureus; skin infection model |
| RmlB (P. aeruginosa) | Pseudomonas infections | Knockout; biofilm formation assay |
| GMDS (human) | Leukocyte adhesion deficiency II | CRISPR knock-in of patient mutations in cell lines |
Bacterial Infections
dTDP-glucose 4,6-dehydratase is essential for the biosynthesis of rhamnose-containing cell wall polysaccharides in pathogenic bacteria such as Mycobacterium tuberculosis, Staphylococcus aureus, and Pseudomonas aeruginosa. Inhibition of this enzyme leads to defective cell walls and reduced virulence, making it a target for novel antibiotics.
Fungal Pathogenesis
In Candida albicans, UDP-glucose 4,6-dehydratase activity is required for cell wall integrity and virulence. Knockout of the encoding gene results in attenuated virulence in mouse models, highlighting its potential as an antifungal target.
Metabolic Disorders
In humans, the homologous enzyme GDP-mannose 4,6-dehydratase (GMDS) is involved in fucosylation pathways. Defects in fucosylation are associated with leukocyte adhesion deficiency type II, a rare immunodeficiency. However, direct links between dTDP-glucose 4,6-dehydratase and human disease are limited to its role in microbial pathogenesis.
From dTDP-glucose 4,6-dehydratase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Enzyme mechanism and kinetics | Point mutations in RmlB (e.g., T134A, Y160F, K164A) |
| Role in cell wall biosynthesis | Knockout of RmlB in bacteria or fungi |
| Drug target validation | Knockout and inhibitor treatment in M. tuberculosis |
| Substrate specificity | Overexpression of wild-type and mutant RmlB |
| Protein-protein interactions | Tagged knock-in of RmlB (e.g., FLAG, GFP) |
| Transcriptional regulation | Knock-in of reporter genes (lacZ, GFP) under rml promoter |
How to Study the dTDP-glucose 4,6-dehydratase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay | NADH formation at 340 nm | Kinetic characterization |
| HPLC | Substrate and product concentrations | Enzyme activity in cell lysates |
| Rapid mix-quench MS | Transient intermediates | Mechanistic studies |
| Site-directed mutagenesis | Effect of point mutations on activity | Active-site residue identification |
| High-throughput screening | Inhibition of enzyme activity | Drug discovery |
| X-ray crystallography | 3D structure | Structure-function analysis |
| Knockout models | Loss of function phenotype | Virulence studies |
Enzymatic Assays
dTDP-glucose 4,6-dehydratase activity can be measured spectrophotometrically by monitoring NADH formation at 340 nm or by high-performance liquid chromatography (HPLC) to detect substrate and product. A 96-well microtiter plate assay has been developed for high-throughput screening of inhibitors.
Mass Spectrometry
Rapid mix-quench mass spectrometry allows real-time monitoring of the reaction intermediates, providing insights into the kinetic mechanism and the order of substrate binding and product release.
Site-Directed Mutagenesis
Mutating active-site residues (e.g., Thr134, Tyr160, Lys164, Glu136, Asp135) followed by kinetic characterization has been instrumental in identifying catalytic roles and the stepwise nature of the reaction.
Structural Biology
X-ray crystallography and cryo-electron microscopy can determine the three-dimensional structure of the enzyme in complex with substrates and cofactors, revealing the architecture of the active site and guiding inhibitor design.
How CRISPR Can Be Used to Study GO:0008460 dTDP-glucose 4,6-dehydratase activity
Knockout
CRISPR-Cas9 knockout of the gene encoding dTDP-glucose 4,6-dehydratase (e.g., rmlB) in bacteria or fungi results in loss of enzyme activity, defective cell wall synthesis, and attenuated virulence. Such models are valuable for validating the enzyme as a drug target and studying its role in pathogenesis.
Point Mutation
CRISPR-mediated point mutations can introduce specific amino acid substitutions (e.g., T134A, Y160F, K164A) to dissect the catalytic mechanism and identify essential residues. These models complement traditional site-directed mutagenesis by enabling endogenous expression levels.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins (e.g., GFP) at the endogenous locus allows real-time visualization and immunoprecipitation of the enzyme, facilitating studies on localization, interactions, and dynamics.
Overexpression
CRISPR activation (CRISPRa) or plasmid-based overexpression of dTDP-glucose 4,6-dehydratase can be used to produce large quantities of the enzyme for biochemical assays, structural studies, or to enhance metabolic flux towards dTDP-rhamnose.
How EDITGENE Supports dTDP-glucose 4,6-dehydratase activity Research
Researchers studying dTDP-glucose 4,6-dehydratase activity-related genes often need to determine whether a candidate gene is causally involved in cell wall biosynthesis, virulence, or drug resistance. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for functional validation.
Contact EDITGENE today to design your custom CRISPR model for dTDP-glucose 4,6-dehydratase activity research.
Frequently Asked Questions About dTDP-glucose 4,6-dehydratase activity
What is dTDP-glucose 4,6-dehydratase activity?
It is a molecular function (GO:0008460) that catalyzes the conversion of dTDP-glucose to dTDP-4-dehydro-6-deoxy-alpha-D-glucose and water, the first step in dTDP-rhamnose biosynthesis.
What genes are involved in dTDP-glucose 4,6-dehydratase activity?
The primary gene is rmlB in bacteria and fungi, but homologous genes include GMDS in humans and Gmd in other organisms.
What is the mechanism of dTDP-glucose 4,6-dehydratase?
The enzyme uses NAD+ to oxidize the substrate, then dehydrates it, and finally reduces the intermediate to form the product.
Which residues are critical for catalysis?
Thr134, Tyr160, Lys164, Glu136, and Asp135 have been identified as key catalytic residues.
Is dTDP-glucose 4,6-dehydratase a drug target?
Yes, it is a validated target for antibacterial and antifungal drugs, with high-throughput screening assays developed for Mycobacterium tuberculosis.
How is dTDP-glucose 4,6-dehydratase activity measured?
It can be measured spectrophotometrically by NADH formation, by HPLC, or by mass spectrometry.
What diseases are associated with dTDP-glucose 4,6-dehydratase?
It is associated with bacterial and fungal infections, as its inhibition attenuates virulence.
Can CRISPR be used to study dTDP-glucose 4,6-dehydratase?
Yes, CRISPR knockout, point mutation, and knock-in models enable precise functional studies.
What is the role of dTDP-glucose 4,6-dehydratase in cell wall synthesis?
It provides the precursor for dTDP-rhamnose, which is incorporated into cell wall polysaccharides.
Are there human homologs of dTDP-glucose 4,6-dehydratase?
Yes, GMDS (GDP-mannose 4,6-dehydratase) is a human homolog involved in fucosylation, but it acts on GDP-mannose rather than dTDP-glucose.
Conclusion
dTDP-glucose 4,6-dehydratase activity (GO:0008460) is a fundamental enzymatic function in carbohydrate metabolism, essential for the biosynthesis of dTDP-rhamnose and cell wall polysaccharides in pathogenic microorganisms. Its well-characterized mechanism, validated role in virulence, and potential as a drug target make it a compelling subject for both basic and applied research. CRISPR-based models offer powerful tools to further dissect its function and regulation.
References
- 1. Gross JW et al.. 2000. Characterization of enzymatic processes by rapid mix-quench mass spectrometry: the case of dTDP-glucose 4,6-dehydratase.. Biochemistry 39(45):13633-40 PMID: 11076501
- 2. Hegeman AD et al.. 2002. Concerted and stepwise dehydration mechanisms observed in wild-type and mutated Escherichia coli dTDP-glucose 4,6-dehydratase.. Biochemistry 41(8):2797-804 PMID: 11851427
- 3. Gerratana B et al.. 2001. Mechanistic roles of Thr134, Tyr160, and Lys 164 in the reaction catalyzed by dTDP-glucose 4,6-dehydratase.. Biochemistry 40(31):9187-95 PMID: 11478886
- 4. Gross JW et al.. 2001. Dehydration is catalyzed by glutamate-136 and aspartic acid-135 active site residues in Escherichia coli dTDP-glucose 4,6-dehydratase.. Biochemistry 40(42):12497-504 PMID: 11601973
- 5. Hegeman AD et al.. 2001. Probing catalysis by Escherichia coli dTDP-glucose-4,6-dehydratase: identification and preliminary characterization of functional amino acid residues at the active site.. Biochemistry 40(22):6598-610 PMID: 11380254
- 6. Shi X et al.. 2016. A 96-well microtiter plate assay for high-throughput screening of Mycobacterium tuberculosis dTDP-d-glucose 4,6-dehydratase inhibitors.. Anal Biochem 498:53-8 PMID: 26778528
- 7. Oh J et al.. 2003. One-pot enzymatic production of dTDP-4-keto-6-deoxy-D-glucose from dTMP and glucose-1-phosphate.. Biotechnol Bioeng 84(4):452-8 PMID: 14574703
- 8. Sen M et al.. 2011. UDP-glucose 4, 6-dehydratase activity plays an important role in maintaining cell wall integrity and virulence of Candida albicans.. PLoS Pathog 7(11):e1002384 PMID: 22114559
